Familial Mediterranean fever (FMF) is a hereditary disease commonly found among Jews, Armenians, Turks and Arabs. Recently, FMF was found in the 'Chuetas', a unique community on the island of Mallorca (Spain). To address the question of their possible Jewish origin, we analysed markers known to be linked to the gene responsible for FMF in Jews (MEFV) in this population. We found that 1/3 of the 16p13.3 chromosomes of the 'Chuetas' FMF patients bore the major ancestral haplotypes (S,S2) and their corresponding M694V and E148Q mutations, displayed by Jews from North Africa. Furthermore, we also detected a novel mutation (L110P) in this community. Yet 2/3 of these patients bore S negative haplotypes and lack the mutations commonly known to cause FMF. These results confirm that at least some of the 'Chuetas' share a common origin with Jews. However, they also provide evidence for the possibility of genetic heterogeneity in this disorder.
Introduction
Familial Mediterranean fever (FMF) or recurrent polyserositis is a hereditary disease characterised by recurrent attacks of fever, transient peritonitis, pleuritis or synovitis, usually lasting from 1 to 3 days. 1 The disease occurs predominantly in populations inhabiting or originating from the Mediterranean basin. Recently we encountered a cluster of FMF patients among a unique closed community called Chuetas on the island of Mallorca. 2 The exact origin of this population is still obscure. It has been suggested that the Chuetas may be descendants of Sephardic (non-Ashkenazi) Jews converted in the Middle Ages. Although the disease is phenotypically very similar in the Chuetas and the NorthAfrican Jewish patients, a previous analysis of several enzymes and blood groups disclosed that, genetically, the Chuetas resembled more the natives of the island. 3, 4 A gene (MEFV) responsible for the disease was located on chromosome 16p13.3, 5 refined to a 0 cM interval, 6 then identified independently by the International FMF Consortium 7 and by the French FMF Consortium. 8 We and others 9 have found two ancestral haplotypes (S and S2) in 71-93% of the FMF chromosomes in Jews from North Africa, which contain the M694V and E148Q MEFV mutations. 7, 8 We have now analysed the genotype of a number of Chuetas FMF patients in order to determine if they share genetic features with North-African Jews who have FMF.
Patients and methods

Patients
Eight families (29 members, 16 FMF patients) were included in the present work ( Figure 1 ). Criteria for diagnosis of FMF included typical history of recurrent febrile episodes accompanied by peritonitis, pleuritis, synovitis or erysipelas-like skin lesion with a family history of FMF or favourable response to colchicine treatment. 1 Some of their clinical features are summarised in Table 1 . None of the patients experienced headache or swollen lymph nodes during the acute attacks. They had neither conjunctivitis nor periorbital oedema as manifestations of their acute episodes. The average duration of a FMF attack in this population was about 2 days. All participants gave their informed consent to be included in the study.
DNA analysis
Blood was collected in EDTA, genomic DNA was extracted 10 and genotyping was carried out as previously described. 6 Information concerning the primers used for amplification of the microsatellite markers was obtained from the Genome Data Base (GDB). The common MEFV gene mutations were searched using appropriate primers and restriction enzymes. 8, 11 When none of the previously known mutations was found the complete coding sequence of the gene and the intronic boundaries were sequenced in both directions as described previously.
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Results
The family pedigrees are depicted in Figure 1 . A series of nine 16p13.3 microsatellite markers (D16S283, D16S3070, D16S3082, D16S3370, D16S2617, D16S3373, D16S3275, D16S475, D16S2622) were analysed. We found three families (six unrelated chromosomes) with the S haplotype, the major FMF haplotype in Jews from North Africa, and one family with the S2 haplotype, the second most frequent haplotype in this population (Figures 1 and 2 ). In the mutation-negative carrier chromosomes, we found haplotype sharing between 182 (11) and 183 (23) and between 183 (33) and 184 (61). Since
(1) examination of the pedigrees was not always consistent with linkage to chromosome 16, (2) none of the known mutations were detected in about 70% of the 16p13.3 chromosomes in the affected patients and (3) mild still unknown mutations could account for these findings,
Figure 1
Pedigrees of eight Chuetas families analysed in the study. Filled symbols represent individuals with familial Mediterranean fever (FMF). Under each individual are the individual number, the mutation(s) he/she carries, (with a slash if they are on different chromosomes or one below the other if they are allelic). When DNA from a patient was sequenced and no mutation was found a ? was added. In patient 183-33 the mutations could not be phased so they were marked on the same line. No new mutation was detected in most of these patients. However, in patient 175-22 we found a substitution L110P in exon 2, which was on the same allele as the E148Q mutation. Two other mutations (R408Q and P369S located in exon 3) were found in individual 183-33, who also bore E148Q mutation ( Figure 2 ). To determine whether these three substitutions were true mutations or polymorphisms, we analysed a wider series of other FMF chromosomes with no mutation in exon 10, and normal chromosomes ascertained through segregation analysis. These chromosomes were mostly chosen from nonAshkenazi Jews, which was the best matched population in the present haplotype study. L110P created an Ava1 restriction site, P369S an Alu1 site and R408Q destroyed an HpaII site. Thus, these mutations could easily be screened by means of RFLP. P369S and R408Q were found once in 28 FMF and once in 87 normal chromosomes. In the normal chromosome (from a non-Ashkenazi Jew) these two sequence variants were on the same allele. L110P was found in two out of 110 FMF chromosomes (the second was from a Turkish patient, also in a complex allele associating E148Q) but not in 150 normal chromosomes.
Discussion
The majority of Israeli patients are descendants of Jewish refugees who emigrated to North Africa from the Iberian peninsula at the end of the 15th century following persecution and expulsion. The finding of a cluster of FMF patients exclusively among the Chuetas while the disease is unknown among non-Chuetas inhabitants of Mallorca, raised the question of their possible Jewish origin. We genotyped eight Chuetas FMF families and showed that three of them had the S haplotype, which is specific for the North-African FMF Jewish patients. One family bore the S2 haplotype, which is also common among FMF Jews. Therefore, it is likely that at least part of these two populations (Chuetas and Jews) acquired the FMF gene defect from a common Spanish ancestry. Nevertheless, some Chuetas patients bore an S negative haplotype and this finding needs to be explained.
One possibility is that some of the S negative and positive FMF chromosomes were derived from ancient Jewish sailors who came from the Middle East to North Africa, Palma de Mallorca and Spain in Biblical times. 7 Another possibility is that de novo mutations arose in these chromosomes among the Chuetas. Indeed, we sequenced the complete coding region of the gene in those patients and detected three substitutions, two of which, P369S and R408Q, were recently reported by Aksentijevich et al 12, 13 and by Cazeneuve et al, 14 respectively. The third substitution, L110P, is a novel mutation which has not yet been described. In patients in whom no mutations were found a number of theories could be invoked. First, some of the patients may suffer from one of the periodic syndromes resembling FMF rather than from true FMF. [15] [16] [17] [18] However, Chuetas patients did not have features typical of TNFR1-associated periodic syndromes (TRAPS) or hyper IgD syndrome (HIDS). [16] [17] [18] Second, the mutations could lie elsewhere in sites other than in the coding region, eg in the promoter, within an intron, or in the 3' UTR. If such as yet unknown mutations do exist, it is still possible that some of these families are linked to 19 No other gene involved in FMF has yet been identified and it is possible that another unknown gene is cosegregating in some of the families presented here. 
